Estler, B., Fröhlich, H., Täger, T., & Frankenstein, L. (2026). Affordability of innovation: Cost-effectiveness and budget impact analysis of acoramidis in transthyretin amyloid cardiomyopathy in the German healthcare system. European heart journal - quality of care and clinical outcomes. https://doi.org/10.1093/ehjqcco/qcag093
Style de citation Chicago (17e éd.)Estler, Bent, Hanna Fröhlich, Tobias Täger, et Lutz Frankenstein. "Affordability of Innovation: Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Healthcare System." European Heart Journal - Quality of Care and Clinical Outcomes 2026. https://doi.org/10.1093/ehjqcco/qcag093.
Style de citation MLA (9e éd.)Estler, Bent, et al. "Affordability of Innovation: Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Healthcare System." European Heart Journal - Quality of Care and Clinical Outcomes, 2026, https://doi.org/10.1093/ehjqcco/qcag093.